CA2942143A1 - Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same - Google Patents

Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same Download PDF

Info

Publication number
CA2942143A1
CA2942143A1 CA2942143A CA2942143A CA2942143A1 CA 2942143 A1 CA2942143 A1 CA 2942143A1 CA 2942143 A CA2942143 A CA 2942143A CA 2942143 A CA2942143 A CA 2942143A CA 2942143 A1 CA2942143 A1 CA 2942143A1
Authority
CA
Canada
Prior art keywords
acid
compound
formula
hexafluorophosphate
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2942143A
Other languages
English (en)
French (fr)
Inventor
D. Travis Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stealth Biotherapeutics Corp
Original Assignee
Stealth Biotherapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Corp filed Critical Stealth Biotherapeutics Corp
Publication of CA2942143A1 publication Critical patent/CA2942143A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2942143A 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same Abandoned CA2942143A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461947286P 2014-03-03 2014-03-03
US61/947,286 2014-03-03
PCT/US2014/072267 WO2015134096A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (1)

Publication Number Publication Date
CA2942143A1 true CA2942143A1 (en) 2015-09-11

Family

ID=54055710

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2942143A Abandoned CA2942143A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same

Country Status (7)

Country Link
US (1) US20170081363A1 (enExample)
EP (1) EP3114136A4 (enExample)
JP (1) JP2017512762A (enExample)
CN (1) CN106459169A (enExample)
CA (1) CA2942143A1 (enExample)
HK (1) HK1231493A1 (enExample)
WO (1) WO2015134096A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100376A1 (en) 2013-12-27 2015-07-02 Stealth Peptides International, Inc. Pharmaceutically relevant aromatic-cationic peptides
EP3800192A1 (en) 2015-03-06 2021-04-07 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
JPWO2017043626A1 (ja) * 2015-09-11 2018-06-21 株式会社カネカ 光学活性4−カルバモイル−2,6−ジメチルフェニルアラニン誘導体の製造法
AU2017249218B2 (en) 2016-04-11 2020-08-27 Arcuate Therapeutics, Inc. Chiral peptides
WO2018187400A1 (en) 2017-04-05 2018-10-11 Stealth Biotherapeutics Corp. Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
EP3898653A4 (en) 2018-12-18 2022-08-24 Stealth BioTherapeutics Inc. ANALOGS TARGETING MITOCHONDRIAL DISEASES
JPWO2023132352A1 (enExample) * 2022-01-06 2023-07-13

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000263A2 (en) * 2000-06-14 2002-01-03 Medarex, Inc. Tripeptide prodrug compounds
US7704954B2 (en) * 2003-05-01 2010-04-27 Cornell Research Foundation, Inc. Method and carrier complexes for delivering molecules to cells
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
WO2011116007A1 (en) * 2010-03-15 2011-09-22 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CN105126071A (zh) * 2011-06-14 2015-12-09 康肽德生物医药技术有限公司 芳香族阳离子肽及其用途
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP3459598A1 (en) * 2012-12-06 2019-03-27 Stealth Peptides International, Inc. Combinations of peptide therapeutics and methods for using same

Also Published As

Publication number Publication date
CN106459169A (zh) 2017-02-22
WO2015134096A1 (en) 2015-09-11
EP3114136A4 (en) 2017-11-01
HK1231493A1 (zh) 2017-12-22
JP2017512762A (ja) 2017-05-25
US20170081363A1 (en) 2017-03-23
EP3114136A1 (en) 2017-01-11

Similar Documents

Publication Publication Date Title
CA2942143A1 (en) Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same
CA2935207C (en) Pharmaceutically relevant aromatic-cationic peptides
US12037414B2 (en) Processes for preparing pharmaceutically relevant peptides
ES2826401T3 (es) Procedimiento de preparación de derivados de mostaza de nitrógeno
KR20250129787A (ko) 입체 장애가 있는 트라이-tert-부틸-트립토판(Tbt) 잔기를 포함하는 펩티드 합성 방법
EP4455148A1 (en) Preparation for thiophene derivative
HK40049251A (en) Processes for preparing pharmaceutically relevant peptides
HK1230631B (en) Pharmaceutically relevant aromatic-cationic peptides
CA2831427A1 (en) Prodrugs of d-isoglutamyl-[d/l]-tryptophan
HK1248604B (en) Processes for preparing pharmaceutically relevant peptides
HK1248604A1 (en) Processes for preparing pharmaceutically relevant peptides

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20210315

FZDE Discontinued

Effective date: 20210315

FZDE Discontinued

Effective date: 20210315